Imaging of Vitreous Opacities in a Canadian Population

Not Applicable

Recruiting

• Conditions: Floaters; Vitreous Opacities
• Interventions: Device: SVO-ID

• Registration Number: NCT06204848
• Lead Sponsor: PulseMedica

Brief Summary

The goal of this clinical trial is to capture imaging data of eye floaters in the population to build an imaging database to learn more about them in. Participants will imaged with an investigational ophthalmic imaging device to capture images of their floaters.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2024-01-03
• Study First Submitted QC: 2024-01-03
• Study First Posted: 2024-01-12
• Study Start: 2024-11-12
• Status Verified: 2025-01
• Last Update Submitted: 2025-01-28
• Last Update Posted: 2025-01-30
• Primary Completion: 2025-06
• Study Completion: 2025-06

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 125

Inclusion Criteria

• Aged 18 years or older
• Symptomatic vitreous opacities (floaters) in vision
• Clear ocular media, to allow a clear view of the vitreous for the SVO-ID

Exclusion Criteria

• Younger than 18 years of age
• Presence of vitreous hemorrhage
• Cataract Grade 3 and above
• Opacification of lens, cornea, or vitreous
• Diagnosis of narrow angle glaucoma
• Refractive error is outside the range of -6D to+3D
• Astigmatism is outside the range of +/-2D of cylinder

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Imaging using the SVO-ID	SVO-ID	Patients will have their eyes imaged with the SVO-ID as part of a study visit.

Primary Outcome Measures

Name	Time	Method
Successful capture of SLO and OCT imaging data of SVOs for algorithm development	Through study completion, an average of 6-8 months	Successful collection of SLO and OCT imaging data

Secondary Outcome Measures

Name	Time	Method
Collection of patient-reported symptoms	Through study completion, an average of 6-8 months	Patient feedback regarding symptoms related to SVOs being imaged

Trial Locations

Locations (1)

Alberta Retina Consultants; 🇨🇦 Edmonton, Alberta, Canada